Objective: Familiarize clinicians with recent information regarding the diagnosis and treatment of ST-segment elevation myocardial infarction.
Data Sources: PubMed search and review of relevant medical literature.
Summary: Definition, pathophysiology, clinical presentation, diagnosis, and treatment of ST-segment elevation myocardial infarction are reviewed.
Conclusions: Patients with ST-segment elevation myocardial infarction benefit from prompt reperfusion therapy. Adjunctive antianginal, antiplatelet, antithrombotic, beta blocker, angiotensin-converting enzyme inhibitor, and statin agents minimize ongoing cardiac ischemia, prevent thrombus propagation, and reduce the risk of recurrent cardiovascular events.
From the Johns Hopkins School of Medicine (JCT), Baltimore, MD, and the University of Texas Health Science Center at San Antonio (RAL), San Antonio, TX.
The authors have not disclosed any potential conflicts of interest.
For information regarding this article, E-mail: firstname.lastname@example.org